Cargando…
A Modified Method for Reducing Renal Injury in Zoledronic Acid Treatment of Hypercalcemia and Adverse Skeletal Events
AIMS: In this paper, we have reported a previously undescribed risk factor of deterioration of renal function in zoledronic acid treatment of skeletal metastasis – high serum calcium level. Based on this consideration, a modified method of treatment of hypercalcemia (HCM) with zoledronic acid is sug...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680841/ https://www.ncbi.nlm.nih.gov/pubmed/23766597 http://dx.doi.org/10.4103/0973-1075.110239 |